Skip to main content

Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis

Publication ,  Conference
Goyal, A; Chaturvedi, A; Elnabawi, Y; Chung, J; Dey, A; Aberra, T; Belur, A; Rivers, J; Genovese, L; Groenendyk, J; Lerman, J; Joshi, A ...
Published in: Arteriosclerosis, Thrombosis, and Vascular Biology
May 2018

Psoriasis (PSO), a chronic inflammatory disease associated with increased prevalence of both stress and coronary artery disease, provides a model to study the role of perceived stress in cardiovascular (CV) disease. While stress perception quantified as resting amygdala activity (RAA) is associated with CV events, its association psoriasis severity as well subclinical CV indices is not well known. We thus, sought to look into the relationship between RAA, psoriasis area severity index (PASI) score and Non-calcified burden (NCB) in PSO. 150 consecutive PSO patients and 58 healthy volunteers (HV) underwent 18-FDG PET/CT and CCTA scans (Toshiba, 320-detector row) to quantify RAA and NCB respectively. Skin disease severity was assessed as PASI score, RAA as target-to-background ratio (Osirix) and NCB using prior published methods (QAngio). The relationship between them was analyzed using multivariable regressions (STATA 12). Despite older age, both PSO & HV were at low CV risk by traditional risk score. RAA was higher in PSO compared to HV (Table 1). Moreover, PASI score correlated positively with RAA in treatment naïve psoriasis patients (β=0.22, p=0.03). Furthermore, RAA associated with NCB (β=0.27, p<0.001), which persisted independent of traditional risk factors (β=0.19, p<0.001). Similar relationship was not observed in HV. In conclusion, PSO skin disease severity relates to amygdalar activity by 18-FDG PET/CT suggesting the role of chronic inflammatory disease like PSO in triggering perceived psychological stress. Moreover, there is a direct association between amygdalar activity and coronary plaque burden suggesting a role for perceived stress in subclinical CV disease in these patients. Larger studies are needed to confirm these findings.

Duke Scholars

Published In

Arteriosclerosis, Thrombosis, and Vascular Biology

DOI

EISSN

1524-4636

ISSN

1079-5642

Publication Date

May 2018

Volume

38

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goyal, A., Chaturvedi, A., Elnabawi, Y., Chung, J., Dey, A., Aberra, T., … Mehta, N. (2018). Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis. In Arteriosclerosis, Thrombosis, and Vascular Biology (Vol. 38). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/atvb.38.suppl_1.589
Goyal, Aditya, Abhishek Chaturvedi, Youssef Elnabawi, Jonathan Chung, Amit Dey, Tsion Aberra, Agastya Belur, et al. “Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis.” In Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 38. Ovid Technologies (Wolters Kluwer Health), 2018. https://doi.org/10.1161/atvb.38.suppl_1.589.
Goyal A, Chaturvedi A, Elnabawi Y, Chung J, Dey A, Aberra T, et al. Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis. In: Arteriosclerosis, Thrombosis, and Vascular Biology. Ovid Technologies (Wolters Kluwer Health); 2018.
Goyal, Aditya, et al. “Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 38, no. Suppl_1, Ovid Technologies (Wolters Kluwer Health), 2018. Crossref, doi:10.1161/atvb.38.suppl_1.589.
Goyal A, Chaturvedi A, Elnabawi Y, Chung J, Dey A, Aberra T, Belur A, Rivers J, Genovese L, Groenendyk J, Lerman J, Joshi A, Rodante J, Playford M, Bluemke D, Chen M, Gelfand J, Mehta N. Abstract 589: Amygdala Activity Assessed by 18-FDG PET/CT Associates with Coronary Plaque Burden Quantified by Coronary Computed Tomography Angiography in Psoriasis. Arteriosclerosis, Thrombosis, and Vascular Biology. Ovid Technologies (Wolters Kluwer Health); 2018.

Published In

Arteriosclerosis, Thrombosis, and Vascular Biology

DOI

EISSN

1524-4636

ISSN

1079-5642

Publication Date

May 2018

Volume

38

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology